0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Systemic Antifungals Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-26M9211
Home | Market Reports | Health| Pharmacy
Global Systemic Antifungals Market Research Report 2022
BUY CHAPTERS

Global Systemic Antifungals Market Research Report 2025

Code: QYRE-Auto-26M9211
Report
July 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Systemic Antifungals Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Systemic Antifungals Market

Systemic Antifungals Market

The global market for Systemic Antifungals was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Fungal infections are generally divided into superficial infections and deep infections (also known as systemic infections). Superficial fungal infections are often caused by various species of fungi, while deep fungal infections mainly affect internal organs and deep tissues, with a low incidence but a mortality rate of up to 50%. Antifungals are drugs that have the ability to inhibit or kill pathogenic fungi and are used to treat fungal infectious diseases.
Translated with www.DeepL.com/Translator (free version)
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Systemic Antifungals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Antifungals.
The Systemic Antifungals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Systemic Antifungals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Systemic Antifungals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Systemic Antifungals Market Report

Report Metric Details
Report Name Systemic Antifungals Market
CAGR 5%
Segment by Type
  • Injections
  • Oral
Segment by Application
  • Hospital
  • Clinic
  • Drugstores
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MSD, Pfizer, Astellas Pharma, Gilead Sciences, Merck, Bayer, Novartis, Liposome Company, Xian-janssen, CR Pharma, Chiatai Tianqing, Haisco Pharmaceutical, Zhuhai Ebang Pharmaceutical, Livzon Group Livzon Pharmaceutical Factory, Honz Pharmaceutical, Medisan, Chengdu Brilliant Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Systemic Antifungals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Systemic Antifungals Market report?

Ans: The main players in the Systemic Antifungals Market are MSD, Pfizer, Astellas Pharma, Gilead Sciences, Merck, Bayer, Novartis, Liposome Company, Xian-janssen, CR Pharma, Chiatai Tianqing, Haisco Pharmaceutical, Zhuhai Ebang Pharmaceutical, Livzon Group Livzon Pharmaceutical Factory, Honz Pharmaceutical, Medisan, Chengdu Brilliant Pharmaceutical

What are the Application segmentation covered in the Systemic Antifungals Market report?

Ans: The Applications covered in the Systemic Antifungals Market report are Hospital, Clinic, Drugstores, Others

What are the Type segmentation covered in the Systemic Antifungals Market report?

Ans: The Types covered in the Systemic Antifungals Market report are Injections, Oral

Recommended Reports

Antifungal Drug Markets

Systemic & Infectious

Fungal Disease Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Antifungals Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injections
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Systemic Antifungals Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstores
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Systemic Antifungals Market Perspective (2020-2031)
2.2 Global Systemic Antifungals Growth Trends by Region
2.2.1 Global Systemic Antifungals Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Systemic Antifungals Historic Market Size by Region (2020-2025)
2.2.3 Systemic Antifungals Forecasted Market Size by Region (2026-2031)
2.3 Systemic Antifungals Market Dynamics
2.3.1 Systemic Antifungals Industry Trends
2.3.2 Systemic Antifungals Market Drivers
2.3.3 Systemic Antifungals Market Challenges
2.3.4 Systemic Antifungals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Systemic Antifungals Players by Revenue
3.1.1 Global Top Systemic Antifungals Players by Revenue (2020-2025)
3.1.2 Global Systemic Antifungals Revenue Market Share by Players (2020-2025)
3.2 Global Systemic Antifungals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Systemic Antifungals Revenue
3.4 Global Systemic Antifungals Market Concentration Ratio
3.4.1 Global Systemic Antifungals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Antifungals Revenue in 2024
3.5 Global Key Players of Systemic Antifungals Head office and Area Served
3.6 Global Key Players of Systemic Antifungals, Product and Application
3.7 Global Key Players of Systemic Antifungals, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Antifungals Breakdown Data by Type
4.1 Global Systemic Antifungals Historic Market Size by Type (2020-2025)
4.2 Global Systemic Antifungals Forecasted Market Size by Type (2026-2031)
5 Systemic Antifungals Breakdown Data by Application
5.1 Global Systemic Antifungals Historic Market Size by Application (2020-2025)
5.2 Global Systemic Antifungals Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Systemic Antifungals Market Size (2020-2031)
6.2 North America Systemic Antifungals Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Systemic Antifungals Market Size by Country (2020-2025)
6.4 North America Systemic Antifungals Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Systemic Antifungals Market Size (2020-2031)
7.2 Europe Systemic Antifungals Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Systemic Antifungals Market Size by Country (2020-2025)
7.4 Europe Systemic Antifungals Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Systemic Antifungals Market Size (2020-2031)
8.2 Asia-Pacific Systemic Antifungals Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Systemic Antifungals Market Size by Region (2020-2025)
8.4 Asia-Pacific Systemic Antifungals Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Systemic Antifungals Market Size (2020-2031)
9.2 Latin America Systemic Antifungals Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Systemic Antifungals Market Size by Country (2020-2025)
9.4 Latin America Systemic Antifungals Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Systemic Antifungals Market Size (2020-2031)
10.2 Middle East & Africa Systemic Antifungals Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Systemic Antifungals Market Size by Country (2020-2025)
10.4 Middle East & Africa Systemic Antifungals Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MSD
11.1.1 MSD Company Details
11.1.2 MSD Business Overview
11.1.3 MSD Systemic Antifungals Introduction
11.1.4 MSD Revenue in Systemic Antifungals Business (2020-2025)
11.1.5 MSD Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Systemic Antifungals Introduction
11.2.4 Pfizer Revenue in Systemic Antifungals Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Details
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma Systemic Antifungals Introduction
11.3.4 Astellas Pharma Revenue in Systemic Antifungals Business (2020-2025)
11.3.5 Astellas Pharma Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Systemic Antifungals Introduction
11.4.4 Gilead Sciences Revenue in Systemic Antifungals Business (2020-2025)
11.4.5 Gilead Sciences Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Systemic Antifungals Introduction
11.5.4 Merck Revenue in Systemic Antifungals Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Systemic Antifungals Introduction
11.6.4 Bayer Revenue in Systemic Antifungals Business (2020-2025)
11.6.5 Bayer Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Systemic Antifungals Introduction
11.7.4 Novartis Revenue in Systemic Antifungals Business (2020-2025)
11.7.5 Novartis Recent Development
11.8 Liposome Company
11.8.1 Liposome Company Company Details
11.8.2 Liposome Company Business Overview
11.8.3 Liposome Company Systemic Antifungals Introduction
11.8.4 Liposome Company Revenue in Systemic Antifungals Business (2020-2025)
11.8.5 Liposome Company Recent Development
11.9 Xian-janssen
11.9.1 Xian-janssen Company Details
11.9.2 Xian-janssen Business Overview
11.9.3 Xian-janssen Systemic Antifungals Introduction
11.9.4 Xian-janssen Revenue in Systemic Antifungals Business (2020-2025)
11.9.5 Xian-janssen Recent Development
11.10 CR Pharma
11.10.1 CR Pharma Company Details
11.10.2 CR Pharma Business Overview
11.10.3 CR Pharma Systemic Antifungals Introduction
11.10.4 CR Pharma Revenue in Systemic Antifungals Business (2020-2025)
11.10.5 CR Pharma Recent Development
11.11 Chiatai Tianqing
11.11.1 Chiatai Tianqing Company Details
11.11.2 Chiatai Tianqing Business Overview
11.11.3 Chiatai Tianqing Systemic Antifungals Introduction
11.11.4 Chiatai Tianqing Revenue in Systemic Antifungals Business (2020-2025)
11.11.5 Chiatai Tianqing Recent Development
11.12 Haisco Pharmaceutical
11.12.1 Haisco Pharmaceutical Company Details
11.12.2 Haisco Pharmaceutical Business Overview
11.12.3 Haisco Pharmaceutical Systemic Antifungals Introduction
11.12.4 Haisco Pharmaceutical Revenue in Systemic Antifungals Business (2020-2025)
11.12.5 Haisco Pharmaceutical Recent Development
11.13 Zhuhai Ebang Pharmaceutical
11.13.1 Zhuhai Ebang Pharmaceutical Company Details
11.13.2 Zhuhai Ebang Pharmaceutical Business Overview
11.13.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Introduction
11.13.4 Zhuhai Ebang Pharmaceutical Revenue in Systemic Antifungals Business (2020-2025)
11.13.5 Zhuhai Ebang Pharmaceutical Recent Development
11.14 Livzon Group Livzon Pharmaceutical Factory
11.14.1 Livzon Group Livzon Pharmaceutical Factory Company Details
11.14.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
11.14.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Introduction
11.14.4 Livzon Group Livzon Pharmaceutical Factory Revenue in Systemic Antifungals Business (2020-2025)
11.14.5 Livzon Group Livzon Pharmaceutical Factory Recent Development
11.15 Honz Pharmaceutical
11.15.1 Honz Pharmaceutical Company Details
11.15.2 Honz Pharmaceutical Business Overview
11.15.3 Honz Pharmaceutical Systemic Antifungals Introduction
11.15.4 Honz Pharmaceutical Revenue in Systemic Antifungals Business (2020-2025)
11.15.5 Honz Pharmaceutical Recent Development
11.16 Medisan
11.16.1 Medisan Company Details
11.16.2 Medisan Business Overview
11.16.3 Medisan Systemic Antifungals Introduction
11.16.4 Medisan Revenue in Systemic Antifungals Business (2020-2025)
11.16.5 Medisan Recent Development
11.17 Chengdu Brilliant Pharmaceutical
11.17.1 Chengdu Brilliant Pharmaceutical Company Details
11.17.2 Chengdu Brilliant Pharmaceutical Business Overview
11.17.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Introduction
11.17.4 Chengdu Brilliant Pharmaceutical Revenue in Systemic Antifungals Business (2020-2025)
11.17.5 Chengdu Brilliant Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Systemic Antifungals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Injections
 Table 3. Key Players of Oral
 Table 4. Global Systemic Antifungals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Systemic Antifungals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Systemic Antifungals Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Systemic Antifungals Market Share by Region (2020-2025)
 Table 8. Global Systemic Antifungals Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Systemic Antifungals Market Share by Region (2026-2031)
 Table 10. Systemic Antifungals Market Trends
 Table 11. Systemic Antifungals Market Drivers
 Table 12. Systemic Antifungals Market Challenges
 Table 13. Systemic Antifungals Market Restraints
 Table 14. Global Systemic Antifungals Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Systemic Antifungals Market Share by Players (2020-2025)
 Table 16. Global Top Systemic Antifungals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Antifungals as of 2024)
 Table 17. Ranking of Global Top Systemic Antifungals Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Systemic Antifungals Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Systemic Antifungals, Headquarters and Area Served
 Table 20. Global Key Players of Systemic Antifungals, Product and Application
 Table 21. Global Key Players of Systemic Antifungals, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Systemic Antifungals Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Systemic Antifungals Revenue Market Share by Type (2020-2025)
 Table 25. Global Systemic Antifungals Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Systemic Antifungals Revenue Market Share by Type (2026-2031)
 Table 27. Global Systemic Antifungals Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Systemic Antifungals Revenue Market Share by Application (2020-2025)
 Table 29. Global Systemic Antifungals Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Systemic Antifungals Revenue Market Share by Application (2026-2031)
 Table 31. North America Systemic Antifungals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Systemic Antifungals Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Systemic Antifungals Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Systemic Antifungals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Systemic Antifungals Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Systemic Antifungals Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Systemic Antifungals Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Systemic Antifungals Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Systemic Antifungals Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Systemic Antifungals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Systemic Antifungals Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Systemic Antifungals Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Systemic Antifungals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Systemic Antifungals Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Systemic Antifungals Market Size by Country (2026-2031) & (US$ Million)
 Table 46. MSD Company Details
 Table 47. MSD Business Overview
 Table 48. MSD Systemic Antifungals Product
 Table 49. MSD Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 50. MSD Recent Development
 Table 51. Pfizer Company Details
 Table 52. Pfizer Business Overview
 Table 53. Pfizer Systemic Antifungals Product
 Table 54. Pfizer Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 55. Pfizer Recent Development
 Table 56. Astellas Pharma Company Details
 Table 57. Astellas Pharma Business Overview
 Table 58. Astellas Pharma Systemic Antifungals Product
 Table 59. Astellas Pharma Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 60. Astellas Pharma Recent Development
 Table 61. Gilead Sciences Company Details
 Table 62. Gilead Sciences Business Overview
 Table 63. Gilead Sciences Systemic Antifungals Product
 Table 64. Gilead Sciences Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 65. Gilead Sciences Recent Development
 Table 66. Merck Company Details
 Table 67. Merck Business Overview
 Table 68. Merck Systemic Antifungals Product
 Table 69. Merck Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 70. Merck Recent Development
 Table 71. Bayer Company Details
 Table 72. Bayer Business Overview
 Table 73. Bayer Systemic Antifungals Product
 Table 74. Bayer Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 75. Bayer Recent Development
 Table 76. Novartis Company Details
 Table 77. Novartis Business Overview
 Table 78. Novartis Systemic Antifungals Product
 Table 79. Novartis Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 80. Novartis Recent Development
 Table 81. Liposome Company Company Details
 Table 82. Liposome Company Business Overview
 Table 83. Liposome Company Systemic Antifungals Product
 Table 84. Liposome Company Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 85. Liposome Company Recent Development
 Table 86. Xian-janssen Company Details
 Table 87. Xian-janssen Business Overview
 Table 88. Xian-janssen Systemic Antifungals Product
 Table 89. Xian-janssen Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 90. Xian-janssen Recent Development
 Table 91. CR Pharma Company Details
 Table 92. CR Pharma Business Overview
 Table 93. CR Pharma Systemic Antifungals Product
 Table 94. CR Pharma Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 95. CR Pharma Recent Development
 Table 96. Chiatai Tianqing Company Details
 Table 97. Chiatai Tianqing Business Overview
 Table 98. Chiatai Tianqing Systemic Antifungals Product
 Table 99. Chiatai Tianqing Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 100. Chiatai Tianqing Recent Development
 Table 101. Haisco Pharmaceutical Company Details
 Table 102. Haisco Pharmaceutical Business Overview
 Table 103. Haisco Pharmaceutical Systemic Antifungals Product
 Table 104. Haisco Pharmaceutical Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 105. Haisco Pharmaceutical Recent Development
 Table 106. Zhuhai Ebang Pharmaceutical Company Details
 Table 107. Zhuhai Ebang Pharmaceutical Business Overview
 Table 108. Zhuhai Ebang Pharmaceutical Systemic Antifungals Product
 Table 109. Zhuhai Ebang Pharmaceutical Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 110. Zhuhai Ebang Pharmaceutical Recent Development
 Table 111. Livzon Group Livzon Pharmaceutical Factory Company Details
 Table 112. Livzon Group Livzon Pharmaceutical Factory Business Overview
 Table 113. Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product
 Table 114. Livzon Group Livzon Pharmaceutical Factory Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 115. Livzon Group Livzon Pharmaceutical Factory Recent Development
 Table 116. Honz Pharmaceutical Company Details
 Table 117. Honz Pharmaceutical Business Overview
 Table 118. Honz Pharmaceutical Systemic Antifungals Product
 Table 119. Honz Pharmaceutical Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 120. Honz Pharmaceutical Recent Development
 Table 121. Medisan Company Details
 Table 122. Medisan Business Overview
 Table 123. Medisan Systemic Antifungals Product
 Table 124. Medisan Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 125. Medisan Recent Development
 Table 126. Chengdu Brilliant Pharmaceutical Company Details
 Table 127. Chengdu Brilliant Pharmaceutical Business Overview
 Table 128. Chengdu Brilliant Pharmaceutical Systemic Antifungals Product
 Table 129. Chengdu Brilliant Pharmaceutical Revenue in Systemic Antifungals Business (2020-2025) & (US$ Million)
 Table 130. Chengdu Brilliant Pharmaceutical Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Systemic Antifungals Picture
 Figure 2. Global Systemic Antifungals Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Systemic Antifungals Market Share by Type: 2024 VS 2031
 Figure 4. Injections Features
 Figure 5. Oral Features
 Figure 6. Global Systemic Antifungals Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Systemic Antifungals Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Drugstores Case Studies
 Figure 11. Others Case Studies
 Figure 12. Systemic Antifungals Report Years Considered
 Figure 13. Global Systemic Antifungals Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Systemic Antifungals Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Systemic Antifungals Market Share by Region: 2024 VS 2031
 Figure 16. Global Systemic Antifungals Market Share by Players in 2024
 Figure 17. Global Top Systemic Antifungals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Antifungals as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Systemic Antifungals Revenue in 2024
 Figure 19. North America Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Systemic Antifungals Market Share by Country (2020-2031)
 Figure 21. United States Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Systemic Antifungals Market Share by Country (2020-2031)
 Figure 25. Germany Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Systemic Antifungals Market Share by Region (2020-2031)
 Figure 33. China Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Systemic Antifungals Market Share by Country (2020-2031)
 Figure 41. Mexico Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Systemic Antifungals Market Share by Country (2020-2031)
 Figure 45. Turkey Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Systemic Antifungals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. MSD Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 49. Pfizer Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 50. Astellas Pharma Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 51. Gilead Sciences Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 52. Merck Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 53. Bayer Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 54. Novartis Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 55. Liposome Company Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 56. Xian-janssen Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 57. CR Pharma Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 58. Chiatai Tianqing Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 59. Haisco Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 60. Zhuhai Ebang Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 61. Livzon Group Livzon Pharmaceutical Factory Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 62. Honz Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 63. Medisan Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 64. Chengdu Brilliant Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart